Literature DB >> 19383377

Large-scale genomic analysis of ovarian carcinomas.

Kylie L Gorringe1, Ian G Campbell.   

Abstract

Epithelial ovarian cancers are typified by frequent genomic aberrations that have been difficult to unravel. Recently, high-resolution array technologies have provided the first glimpse of the remarkable complexity of these aberrations with some ovarian cancers containing hundreds of copy number breakpoints, micro-deletions and amplifications. Many of these alterations contain cancer-related genes suggesting that the majority is disease-associated and not just the product of random genomic instability. Future developments such as next-generation sequencing and integrated analysis of data from multiple array platforms on large numbers of samples are poised to revolutionize our understanding of this complex disease.

Entities:  

Mesh:

Year:  2008        PMID: 19383377      PMCID: PMC5527877          DOI: 10.1016/j.molonc.2008.12.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  56 in total

1.  Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.

Authors:  Graham R Bignell; Thomas Santarius; Jessica C M Pole; Adam P Butler; Janet Perry; Erin Pleasance; Chris Greenman; Andrew Menzies; Sheila Taylor; Sarah Edkins; Peter Campbell; Michael Quail; Bob Plumb; Lucy Matthews; Kirsten McLay; Paul A W Edwards; Jane Rogers; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Genome Res       Date:  2007-08-03       Impact factor: 9.043

2.  Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.

Authors:  Sang Wun Kim; Jae Wook Kim; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Bo Sung Yoon; Eun Ji Nam; Hye Yeon Kim
Journal:  Genes Chromosomes Cancer       Date:  2007-01       Impact factor: 5.006

3.  Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.

Authors:  Colleen M Feltmate; Kenneth R Lee; Michael Johnson; John O Schorge; Kwong-Kwok Wong; Ke Hao; William R Welch; Debra A Bell; Ross S Berkowitz; Samuel C Mok
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

4.  Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.

Authors:  G Sonoda; J Palazzo; S du Manoir; A K Godwin; M Feder; M Yakushiji; J R Testa
Journal:  Genes Chromosomes Cancer       Date:  1997-12       Impact factor: 5.006

5.  In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential.

Authors:  C J Haas; J Diebold; A Hirschmann; H Rohrbach; U Löhrs
Journal:  Virchows Arch       Date:  1999-02       Impact factor: 4.064

6.  High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.

Authors:  Marcus Bernardini; Chung-Hae Lee; Ben Beheshti; Mona Prasad; Monique Albert; Paula Marrano; Heather Begley; Patricia Shaw; Al Covens; Joan Murphy; Barry Rosen; Salomon Minkin; Jeremy A Squire; Pascale F Macgregor
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

Review 7.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

8.  Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing.

Authors:  Peter J Campbell; Philip J Stephens; Erin D Pleasance; Sarah O'Meara; Heng Li; Thomas Santarius; Lucy A Stebbings; Catherine Leroy; Sarah Edkins; Claire Hardy; Jon W Teague; Andrew Menzies; Ian Goodhead; Daniel J Turner; Christopher M Clee; Michael A Quail; Antony Cox; Clive Brown; Richard Durbin; Matthew E Hurles; Paul A W Edwards; Graham R Bignell; Michael R Stratton; P Andrew Futreal
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

9.  Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.

Authors:  Sharoni Jacobs; Ella R Thompson; Yasuhito Nannya; Go Yamamoto; Raji Pillai; Seishi Ogawa; Dione K Bailey; Ian G Campbell
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.

Authors:  Timothy J Ley; Elaine R Mardis; Li Ding; Bob Fulton; Michael D McLellan; Ken Chen; David Dooling; Brian H Dunford-Shore; Sean McGrath; Matthew Hickenbotham; Lisa Cook; Rachel Abbott; David E Larson; Dan C Koboldt; Craig Pohl; Scott Smith; Amy Hawkins; Scott Abbott; Devin Locke; Ladeana W Hillier; Tracie Miner; Lucinda Fulton; Vincent Magrini; Todd Wylie; Jarret Glasscock; Joshua Conyers; Nathan Sander; Xiaoqi Shi; John R Osborne; Patrick Minx; David Gordon; Asif Chinwalla; Yu Zhao; Rhonda E Ries; Jacqueline E Payton; Peter Westervelt; Michael H Tomasson; Mark Watson; Jack Baty; Jennifer Ivanovich; Sharon Heath; William D Shannon; Rakesh Nagarajan; Matthew J Walter; Daniel C Link; Timothy A Graubert; John F DiPersio; Richard K Wilson
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

View more
  16 in total

1.  Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing.

Authors:  Joke Reumers; Peter De Rijk; Hui Zhao; Anthony Liekens; Dominiek Smeets; John Cleary; Peter Van Loo; Maarten Van Den Bossche; Kirsten Catthoor; Bernard Sabbe; Evelyn Despierre; Ignace Vergote; Brian Hilbush; Diether Lambrechts; Jurgen Del-Favero
Journal:  Nat Biotechnol       Date:  2011-12-18       Impact factor: 54.908

2.  An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.

Authors:  Kathryn M Kinross; Karen G Montgomery; Margarete Kleinschmidt; Paul Waring; Ivan Ivetac; Anjali Tikoo; Mirette Saad; Lauren Hare; Vincent Roh; Theo Mantamadiotis; Karen E Sheppard; Georgina L Ryland; Ian G Campbell; Kylie L Gorringe; James G Christensen; Carleen Cullinane; Rodney J Hicks; Richard B Pearson; Ricky W Johnstone; Grant A McArthur; Wayne A Phillips
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

3.  VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.

Authors:  Karen Gambaro; Michael C J Quinn; Paulina M Wojnarowicz; Suzanna L Arcand; Manon de Ladurantaye; Véronique Barrès; Jean-Sébastien Ripeau; Ann M Killary; Elaine C Davis; Josée Lavoie; Diane M Provencher; Anne-Marie Mes-Masson; Mario Chevrette; Patricia N Tonin
Journal:  Mol Oncol       Date:  2013-01-16       Impact factor: 6.603

4.  The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis.

Authors:  Elisabetta Kuhn; Ayse Ayhan; Ie-Ming Shih; Jeffrey D Seidman; Robert J Kurman
Journal:  Mod Pathol       Date:  2013-07-26       Impact factor: 7.842

5.  Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.

Authors:  Jane Bayani; Paula Marrano; Cassandra Graham; Yingye Zheng; Lin Li; Dionyssios Katsaros; Heini Lassus; Ralf Butzow; Jeremy A Squire; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-08-11       Impact factor: 6.603

Review 6.  The genesis and evolution of high-grade serous ovarian cancer.

Authors:  David D L Bowtell
Journal:  Nat Rev Cancer       Date:  2010-10-14       Impact factor: 60.716

7.  Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.

Authors:  Manasa Ramakrishna; Louise H Williams; Samantha E Boyle; Jennifer L Bearfoot; Anita Sridhar; Terence P Speed; Kylie L Gorringe; Ian G Campbell
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

Review 8.  Next-generation sequencing: a transformative tool for vaccinology.

Authors:  Neelam Dhiman; David I Smith; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

Review 9.  Large-scale genomic analysis of ovarian carcinomas.

Authors:  Kylie L Gorringe; Ian G Campbell
Journal:  Mol Oncol       Date:  2008-12-24       Impact factor: 6.603

10.  High levels of genomic aberrations in serous ovarian cancers are associated with better survival.

Authors:  Lars O Baumbusch; Åslaug Helland; Yun Wang; Knut Liestøl; Marci E Schaner; Ruth Holm; Dariush Etemadmoghadam; Kathryn Alsop; Pat Brown; Gillian Mitchell; Sian Fereday; Anna DeFazio; David D L Bowtell; Gunnar B Kristensen; Ole Christian Lingjærde; Anne-Lise Børresen-Dale
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.